CNBC Power Lunch March 19, 2015
Kitchen. Well show you how. Okay. Lets get to it. We begin with what could be Ground Breaking development in the war against alzheimers, the biggest news event in biotech this year and bet your Bottom Dollar investors and us watch closely. Biogen releasing full data tomorrow on the drug. Shares are rising, and in fact high today at 1. 8 as we speak. What is at stake here . Hey, mandy, a lot. Start with the size of the problem, more than 5 million americans currently have al timers disease, and that could triple by 2050 according to the alzheimers association. Its now the sixth leading cause of...
Source: archive.org
